Nilda Mesa
Director · UNITED THERAPEUTICS Corp
- 2024
- Sep 15, 2026
- 8
Summary
Latest filing:
Nilda Mesa is Director of UNITED THERAPEUTICS Corp (UTHR). 8 SEC Form 4 filings on record going back to 2024, most recently on 15 September 2026. Most recent open-market trade: sold $50K of UTHR on 15 September 2026. Lifetime open-market sales: $636K.
Recent transactions
9The latest 9 SEC Form 4 transactions reported by Nilda Mesa.
Trading pattern
InsiderAlpha's records for Nilda Mesa go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nilda Mesa files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
- Christopher Patusky - $2.73M in UTHR purchases and sales in the last 12 months
- Ray Kurzweil - $2.40M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nilda Mesa?
Nilda Mesa is a corporate insider, tracked as Director of UNITED THERAPEUTICS Corp (UTHR). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Nilda Mesa submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Nilda Mesa been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($636K) across all tracked filings.